top of page

Advance Agrolife IPO

  • Oct 2, 2025
  • 2 min read
Advance Agrolife IPO

Company Overview:

Advance Agrolife Limited, incorporated in 2002, is an Indian agrochemical company engaged in the manufacturing, formulation, and distribution of a wide range of crop protection and agro-support products.

The company’s portfolio covers insecticides, herbicides, fungicides, plant growth regulators, fertilizers (micro-nutrients and bio-fertilizers), and technical grade products used in agriculture.

Advance Agrolife serves farmers, agro-based industries, and corporates through a strong B2B sales model, operating across 19 states and 3 union territories in India, while also exporting to UAE, Bangladesh, China (incl. Hong Kong), Turkey, Egypt, Kenya, and Nepal.

The company has three manufacturing facilities located in Jaipur, Rajasthan, with integrated capabilities enabling scale and cost efficiency.


Objects of the Issue:

  1. Funding working capital requirements – ₹135 Cr

  2. General corporate purposes & miscellaneous – ₹57.86 Cr


Strengths:

  • Wide product portfolio across agrochemicals, fertilizers & technical products

  • Strong domestic presence with growing exports

  • In-house R&D driving innovation & compliance

  • Scalable manufacturing with backward integration

  • Demand supported by agri-growth & food security trends

  • B2B model ensures long-term corporate relationships

  • Adherence to global regulatory & quality standards

  • Expanding export potential in Asia, Africa & Middle East

  • Year-round demand with coverage of Kharif & Rabi crops


Risks:

  • Seasonal & monsoon-dependent demand

  • Stringent environmental & regulatory norms

  • Intense competition from global & domestic players

  • Raw material and forex price volatility

  • High working capital requirements

  • Exposure to export trade & geopolitical risks

  • Dependence on distribution networks & credit cycles

  • Risk from bio-based/organic alternatives

Advance Agrolife IPO: Key Details

  • IPO Dates: 30 – 3 Oct 2025

  • Price Band: ₹95 to ₹100 per share

  • Lot Size: 150 Shares

  • Total Issue Size: ₹192.86 Cr

  • Retail Quota: 35%

  • GMP (for reference only): ~12%

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website. 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating


SEBI Registered Research Analyst Details:
Registered Name:
Aditya Umesh Hujband
SEBI Registration No.: INH000011185
Type of Registration: Individual 
Validity: Jan 03, 2023 - Jan 02, 2028
Registered Office Address: Haresh Niwas, Room No.487, B.K. No A-82, Near Mahan Apartment, Ulhasnagar, Maharashtra, 421001
Contact No.: +91 9594941559
Email: hujbandaditya@gmail.com

 

SEBI Office Details: SEBI Bhavan BKC, Address: Plot No.C4-A, 'G' Block Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra | Tel: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22
Email: sebi@sebi.gov.in 
Toll-Free Investor Helpline: 1800 22 7575 
SCORES: https://scores.sebi.gov.in/
SMARTODR: https://smartodr.in/login

Please Note:
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, Enlistment with RAASB/BSE and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.


Disclaimer Link

Sitemap: https://www.mbainvestmentwala.com/sitemap

 

Accessibility Assistance: 

  • We are committed to making our website accessible and user-friendly for all visitors, including persons with disabilities, in line with applicable SEBI accessibility requirements.

  • If you experience any difficulty accessing any part of this website, encounter inaccessible content, or require information in an alternative format, please feel free to contact us. We will make reasonable efforts to provide the requested information and resolve the issue at the earliest. 

  • Accessibility Statement: Accessibility Statement Link

 Contact Details:

 1. Phone: +91 9594941599
2. Email: mbainvestmentwala@gmail.com
We sincerely apologise for any inconvenience caused.

 

Aditya Hujband
SEBI Registration No. INH000011185

  • MBA Investmentwala on Quora
  • MBA Investmentwala Whatsapp Link
  • alt.text.label.Instagram
  • alt.text.label.Twitter
bottom of page